NCT05199441View on ClinicalTrials.gov

Efficacy of Galeo® in Patients With Postprandial Distress Syndrome Subtype in Functional Dyspepsia

PHASE4CompletedINTERVENTIONAL
Enrollment

226

Participants

Timeline

Start Date

February 25, 2022

Primary Completion Date

July 5, 2023

Study Completion Date

July 7, 2023

Conditions
Dyspepsia
Interventions
DRUG

Dihydroxydibutylether group

This group takes 1.500 mg/day of dihydroxydibutylether for 8 weeks.

DRUG

Control group placebo

This group takes 1,500 mg/day of placebo for 8 weeks.

Trial Locations (1)

50612

Pusan National University Yangsan Hospital, Yangsan

All Listed Sponsors
lead

Pusan National University Yangsan Hospital

OTHER